Found: 30
Select item for more details and to access through your institution.
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 823, doi. 10.1007/s00432-014-1610-x
- By:
- Publication type:
- Article
Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the Chest.
- Published in:
- Acta Oncologica, 1999, v. 38, n. 6, p. 799, doi. 10.1080/028418699432969
- By:
- Publication type:
- Article
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study).
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 5, p. 272, doi. 10.1159/000522043
- By:
- Publication type:
- Article
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 7/8, p. 333, doi. 10.1159/000508450
- By:
- Publication type:
- Article
Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 3, p. 128, doi. 10.1159/000495366
- By:
- Publication type:
- Article
Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 1/2, p. 57, doi. 10.1159/000494278
- By:
- Publication type:
- Article
Welche Chancen bietet die Immunonkologie für ein indikationsübergreifendes Langzeitüberleben?
- Published in:
- Oncology Research & Treatment, 2015, v. 38, p. 6, doi. 10.1159/000381363
- By:
- Publication type:
- Article
Treatment Algorithm for Metastatic Renal Cell Carcinoma - Recommendations Based on Evidence and Clinical Practice.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 3, p. 136, doi. 10.1159/000360179
- By:
- Publication type:
- Article
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 3, p. 95, doi. 10.1159/000348522
- By:
- Publication type:
- Article
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials.
- Published in:
- Cancer (0008543X), 1993, v. 72, n. 2, p. 607, doi. 10.1002/1097-0142(19930715)72:2<607::AID-CNCR2820720245>3.0.CO;2-R
- By:
- Publication type:
- Article
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1184, doi. 10.1007/s10637-011-9665-x
- By:
- Publication type:
- Article
CD30-mediated cell cycle arrest associated with induced expression of p21<sup>CIP1/WAF1</sup> in the anaplastic large cell lymphoma cell line Karpas 299.
- Published in:
- Oncogene, 2001, v. 20, n. 5, p. 590
- By:
- Publication type:
- Article
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 5, p. 426, doi. 10.1111/j.1600-0609.2011.01680.x
- By:
- Publication type:
- Article
High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2005, v. 84, n. 11, p. 748, doi. 10.1007/s00277-005-1075-8
- By:
- Publication type:
- Article
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1097, doi. 10.1007/s00280-008-0835-2
- By:
- Publication type:
- Article
A Multifocal Malignant Fibrous Histiocytoma of the Bone Evolving From Fibrous Dysplasia.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review.
- Published in:
- Urologia Internationalis, 2024, v. 108, n. 3, p. 198, doi. 10.1159/000536563
- By:
- Publication type:
- Article
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 2, p. 308
- By:
- Publication type:
- Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 102, doi. 10.1634/theoncologist.2015-0276
- By:
- Publication type:
- Article
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1309-7
- By:
- Publication type:
- Article
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic–pituitary–adrenal axis.
- Published in:
- Clinical Endocrinology, 1999, v. 50, n. 1, p. 37, doi. 10.1046/j.1365-2265.1999.00592.x
- By:
- Publication type:
- Article
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 1, p. 80, doi. 10.1046/j.1365-2141.1999.01674.x
- By:
- Publication type:
- Article
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 1, p. 72, doi. 10.1046/j.1365-2141.1998.00926.x
- By:
- Publication type:
- Article
Surface IgM<sub>κ</sub> of Prolymphocytic Leukaemia Cells with Antibody Activity to Surface Antigens of Sheep and Guinea-Pig Red Blood Cells.
- Published in:
- British Journal of Haematology, 1981, v. 48, n. 1, p. 103, doi. 10.1111/j.1365-2141.1981.00103.x
- By:
- Publication type:
- Article
Radioimmunotherapy for the Intensification of Conditioning Before Stem Cell Transplantation: Differences in Dosimetry and Biokinetics of <sup>188</sup>Re-and <sup>99m</sup>Tc-Labeled Anti-NCA-95 MAbs.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 3, p. 531
- By:
- Publication type:
- Article
GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 586, doi. 10.1186/1471-2407-12-586
- By:
- Publication type:
- Article